DXCM Q1 2020 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$405M+44.4% YoY

Gross Profit

$257M63.3% margin

Operating Income

$34M8.3% margin

Net Income

$20M4.9% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

-12.5%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$31M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.5B

Stockholders' Equity

$935M

Cash & Equivalents

$585M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$405M	$281M	+44.4%
Gross Profit	$257M	$169M	+52.0%
Operating Income	$34M	-$14M	+333.3%
Net Income	$20M	-$27M	+174.0%

Geographic Segments

UNITED STATES

$292M72%

Non-US

$113M28%